Innovation is America’s backbone.
It creates jobs here and improves lives everywhere.
Let’s protect it.
Patents Save Lives
From diagnostics to therapeutics and vaccines, patent rights underpin the innovations responsible for saving millions of lives during the Covid-19 pandemic and beyond.
IP Fosters Economic Growth
IP-intensive sectors, from film and music to high-tech manufacturing and life sciences, employ 45 million Americans and account for over one-third of total U.S. GDP.
IP Rights Tackle Global Challenges
Strong patent rights facilitate pioneering discoveries that are fit to address today's energy security, climate change, and public health concerns.
IP Rights Drive High-Value Creative Industries
Strong IP rights, from copyrights to trademarks, incentivize the development of creative works that fuel the economy and benefit the general public.
Predictable and high-quality intellectual property rights have propelled America’s innovative leadership ever since they were enshrined in the Constitution.
Stories of IP in Action
Inventor Spotlight: John B. Goodenough
September 26, 2025
This month, C4IP is honoring John B. Goodenough (1922-2023), whose work on the invention of the lithium-ion battery powers billions of high-tech devices and is reshaping renewable energy. Born in Germany and raised in Connecticut, Goodenough earned his Ph.D. in ...
Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA)
September 25, 2025
This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the U.S. patent system by deciding that certain categories of innovation should not receive patents by widening the “judicial ...
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry
September 19, 2025
Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a crucial role in promoting innovation — both in the drug industry and in other sectors — lawmakers and ...